Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Return on Assets (2016 - 2025)

Historic Return on Assets for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to 0.44%.

  • Fortress Biotech's Return on Assets rose 4300.0% to 0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year increase of 4300.0%. This contributed to the annual value of 0.78% for FY2024, which is 1100.0% down from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Return on Assets is 0.44%, which was up 4300.0% from 0.66% recorded in Q2 2025.
  • Fortress Biotech's Return on Assets' 5-year high stood at 0.28% during Q1 2021, with a 5-year trough of 1.06% in Q3 2023.
  • In the last 5 years, Fortress Biotech's Return on Assets had a median value of 0.66% in 2025 and averaged 0.65%.
  • Per our database at Business Quant, Fortress Biotech's Return on Assets tumbled by -4400bps in 2023 and then skyrocketed by 4300bps in 2025.
  • Fortress Biotech's Return on Assets (Quarter) stood at 0.46% in 2021, then plummeted by -47bps to 0.67% in 2022, then tumbled by -37bps to 0.92% in 2023, then grew by 7bps to 0.86% in 2024, then soared by 49bps to 0.44% in 2025.
  • Its last three reported values are 0.44% in Q3 2025, 0.66% for Q2 2025, and 0.63% during Q1 2025.